Bruker Corporation Majority Investment in RECIPE Chemicals + Instruments GmbH
April 16, 2025
Bruker Corporation announced a majority investment in RECIPE Chemicals + Instruments GmbH, a Munich-based provider of mass spectrometry‑based in vitro diagnostic assay kits for therapeutic drug monitoring. The deal (financial terms undisclosed) brings RECIPE's ClinMASS kits into Bruker's portfolio and creates a strategic collaboration to introduce high‑throughput, chromatography‑free ClinDART workflows on Bruker's EVOQ‑DART TQ⁺ platform.
- Buyers
- Bruker Corporation
- Targets
- RECIPE Chemicals + Instruments GmbH
- Industry
- Medical Devices
- Location
- Bavaria, Germany
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
Bruker Corporation to Acquire ELITech Group from PAI Partners
December 27, 2023
Healthcare Services
PAI Partners has entered into an agreement with Bruker Corporation to sell ELITech Group, a global manufacturer of in-vitro diagnostics (IVD) instruments and reagents. The deal is subject to regulatory and customary closing conditions and includes a put option for the sale. Under PAI’s ownership since 2017, ELITech pursued R&D investments, next-generation molecular diagnostics systems, and strategic partnerships.
-
Calibre Scientific Acquires Chemos GmbH & Co. KG
May 16, 2023
Manufacturing
Calibre Scientific has acquired Chemos GmbH & Co. KG, a Germany-based supplier of ready-to-use laboratory chemicals, reagents, standards and production raw materials. The acquisition adds Chemos' sourcing, formulation and toll-manufacturing capabilities to Calibre's global life-science portfolio to expand product offerings and support customers across analytical, chemical, food and pharmaceutical end markets.
-
908 Devices Acquires TRACE Analytics GmbH
August 9, 2022
Medical Devices
908 Devices (Nasdaq: MASS) has completed the acquisition of TRACE Analytics GmbH, a Braunschweig, Germany-based provider of on-line aseptic sampling systems and biosensors for bioreactor monitoring. The purchase consideration includes $15.3 million in cash up front plus up to $2.0 million of contingent consideration, and 908 Devices says the acquisition will enable its mass spec devices to perform on-line bioprocess monitoring and advance its bioanalytics platform.
-
Bruker Corporation Acquires Prolab Instruments GmbH
January 19, 2022
Medical Devices
Bruker Corporation (Nasdaq: BRKR) has acquired Prolab Instruments GmbH, a Swiss developer of low-flow, high-precision UHPLC pumps, autosamplers and nano-/cap-LC systems, to strengthen its proteomics and metabolomics workflows. Financial terms were not disclosed; Bruker said the acquisition will accelerate product innovation and improve single-cell and high-sensitivity proteomics capabilities.
-
Bruker Corporation Acquires Canopy Biosciences, LLC
September 11, 2020
Biotechnology
Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.